Search Drug By Letter : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

ABBOSYNAGIS Package(a):
VIALS (POWDER) + DILUENT: 1 x 50 mg + 1 ampoule water.
Dosage(a):
The recommended dose is 15 mg/kg body weight given once a month during anticipated periods of RSV risk in the community. See data sheet.
Prescribing Restrictions:  

Package(b):
VIALS (POWDER) + DILUENT: 1 x 100 mg + 1 ampoule water.
Dosage(b):
The recommended dose is 15 mg/kg body weight given once a month during anticipated periods of RSV risk in the community. See data sheet.
Prescribing Restrictions:   
 

Indications:
Prevention of serious lower respiratory tract disorders caused by respiratory synsytial virus (RSV). Infections with bronchopulmonary dysplasia (BPD) infections with history of prematurity (30 weeks gestational age). Hemodynamically significant congenital heart disease (CHD) in children less than 2 years of age.
Contra-Indications:
Known hypersensitivity to palvizumab or any component of the formulation, or other humanized monoclonal antibodies.
Special Precautions:
See prescribing information for full details.
Side Effects:
See prescribing information for full details.
Drug Interactions:
See prescribing information for full details.